0

523696

FORTISMLR

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

FORTIS MALAR HOSPITALS LIMITED Share Price Today

Investment Returns

Over 1 Month -4.60% Over 3 Months 5.45% Over 6 Months -13.48% Over 1 Year -27.64%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

FORTIS MALAR HOSPITALS LIMITED fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 97.90
  • P/E Ratio (TTM) 23.31
  • Beta 0.84
  • Book Value / share 18.22
  • Return on equity 0.59%
  • EPS (TTM) 2.24
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -0.03
info icon alternate text

FORTIS MALAR HOSPITALS LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 0.00
Operating Expense 0.53
Net Profit -0.03
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA 0.12
Effective Tax Rate (%) 125.00
Particulars DEC 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.31
Net Profit 0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.02
EBITDA 0.21
Effective Tax Rate (%) 80.95
Particulars SEP 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.37
Net Profit 0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.01
EBITDA 0.15
Effective Tax Rate (%) 86.66
Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.30
Net Profit 4.18
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 2.23
EBITDA 4.31
Effective Tax Rate (%) 3.01
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.37
Net Profit 0.36
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.19
EBITDA 0.40
Effective Tax Rate (%) 10.00
Particulars MAR 2026 (Values in Cr)
Revenue 0.00
Operating Expense 1.51
Net Profit 4.20
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 2.24
EBITDA 4.79
Effective Tax Rate (%) 12.31
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 2.13
Net Profit 0.41
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.22
EBITDA 0.60
Effective Tax Rate (%) 30.50
Particulars MAR 2024 (Values in Cr)
Revenue 59.01
Operating Expense 73.86
Net Profit 47.28
Net Profit Margin (%) 80.12
Earnings Per Share (EPS) 25.23
EBITDA 65.61
Effective Tax Rate (%) 8.98
Particulars MAR 2023 (Values in Cr)
Revenue 85.95
Operating Expense 99.59
Net Profit -15.53
Net Profit Margin (%) -18.06
Earnings Per Share (EPS) -8.29
EBITDA 11.14
Effective Tax Rate (%) -119.49
Particulars MAR 2022 (Values in Cr)
Revenue 86.18
Operating Expense 101.82
Net Profit -8.31
Net Profit Margin (%) -9.64
Earnings Per Share (EPS) -4.43
EBITDA 10.77
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 16.11
ROE % 0.56
ROCE % 0.83
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 58.36
ROE % -9.12
ROCE % -3.24
Total Debt to Total Equity 0.27
EBITDA Margin 9.73
Particulars MAR 2023 (Values in Cr)
Book Value / Share 34.21
ROE % -21.45
ROCE % -0.75
Total Debt to Total Equity 0.69
EBITDA Margin 13.04
Particulars MAR 2022 (Values in Cr)
Book Value / Share 42.72
ROE % -9.79
ROCE % -1.19
Total Debt to Total Equity 0.65
EBITDA Margin 12.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 47.31
ROE % -15.90
ROCE % -7.05
Total Debt to Total Equity 0.66
EBITDA Margin 2.76
Particulars MAR 2025 (Values in Cr)
Book Value / Share 15.97
ROE % 0.59
ROCE % 0.86
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 58.22
ROE % -6.99
ROCE % -1.52
Total Debt to Total Equity 0.27
EBITDA Margin 13.01
Particulars MAR 2023 (Values in Cr)
Book Value / Share 33.03
ROE % -22.20
ROCE % -0.81
Total Debt to Total Equity 0.71
EBITDA Margin 12.96
Particulars MAR 2022 (Values in Cr)
Book Value / Share 41.57
ROE % -10.10
ROCE % -1.25
Total Debt to Total Equity 0.67
EBITDA Margin 12.52
Particulars MAR 2021 (Values in Cr)
Book Value / Share 46.18
ROE % -16.42
ROCE % -7.24
Total Debt to Total Equity 0.67
EBITDA Margin 2.54
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 17.79
Total Assets 36.83
Total Liabilities 36.83
Total Equity 30.20
Share Outstanding 1
Price to Book Ratio 4.60
Return on Assets (%) 1.06
Return on Capital (%) 1.3
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 108.22
Total Assets 115.87
Total Liabilities 115.87
Total Equity 109.46
Share Outstanding 1
Price to Book Ratio 0.80
Return on Assets (%) 39.11
Return on Capital (%) 41.4
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 9.43
Total Assets 137.99
Total Liabilities 137.99
Total Equity 64.17
Share Outstanding 1
Price to Book Ratio 1.44
Return on Assets (%) -11.21
Return on Capital (%) -24.12
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.55
Total Assets 160.91
Total Liabilities 160.91
Total Equity 80.13
Share Outstanding 1
Price to Book Ratio 1.39
Return on Assets (%) -5.14
Return on Capital (%) -10.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 13.56
Total Assets 169.09
Total Liabilities 169.09
Total Equity 88.74
Share Outstanding 1
Price to Book Ratio 1.20
Return on Assets (%) -4.65
Return on Capital (%) -8.87
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 17.70
Total Assets 36.57
Total Liabilities 36.57
Total Equity 29.96
Share Outstanding 1
Price to Book Ratio 4.60
Return on Assets (%) 1.12
Return on Capital (%) 1.37
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 106.10
Total Assets 115.38
Total Liabilities 115.38
Total Equity 109.20
Share Outstanding 1
Price to Book Ratio 0.80
Return on Assets (%) 40.97
Return on Capital (%) 43.29
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.30
Total Assets 135.69
Total Liabilities 135.69
Total Equity 61.95
Share Outstanding 1
Price to Book Ratio 1.44
Return on Assets (%) -11.44
Return on Capital (%) -25.07
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 10.48
Total Assets 158.67
Total Liabilities 158.67
Total Equity 77.97
Share Outstanding 1
Price to Book Ratio 1.39
Return on Assets (%) -5.23
Return on Capital (%) -10.65
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 11.60
Total Assets 166.98
Total Liabilities 166.98
Total Equity 86.61
Share Outstanding 1
Price to Book Ratio 1.20
Return on Assets (%) -4.79
Return on Capital (%) -9.25
Particulars MAR 2025 (Values in Cr)
Net Income 0.56
Cash from Operations -1.73
Cash from Investing -29.09
Cash from Financing -79.65
Net change in Cash -107.20
Free Cash Flow -1.73
Particulars MAR 2024 (Values in Cr)
Net Income 50.00
Cash from Operations -2.27
Cash from Investing 119.70
Cash from Financing -10.85
Net change in Cash 101.54
Free Cash Flow 0.02
Particulars MAR 2023 (Values in Cr)
Net Income -7.00
Cash from Operations 5.52
Cash from Investing 0.49
Cash from Financing -12.65
Net change in Cash -6.54
Free Cash Flow 7.40
Particulars MAR 2022 (Values in Cr)
Net Income -8.26
Cash from Operations 7.56
Cash from Investing 8.23
Cash from Financing -10.10
Net change in Cash 4.97
Free Cash Flow 8.96
Particulars MAR 2021 (Values in Cr)
Net Income -11.31
Cash from Operations -12.95
Cash from Investing -27.51
Cash from Financing -7.24
Net change in Cash -35.62
Free Cash Flow -12.42
Particulars MAR 2025 (Values in Cr)
Net Income 0.58
Cash from Operations -1.49
Cash from Investing -27.29
Cash from Financing -79.65
Net change in Cash -105.17
Free Cash Flow -1.49
Particulars MAR 2024 (Values in Cr)
Net Income 51.94
Cash from Operations -2.20
Cash from Investing 119.62
Cash from Financing -10.85
Net change in Cash 101.55
Free Cash Flow 0.09
Particulars MAR 2023 (Values in Cr)
Net Income -7.07
Cash from Operations 5.51
Cash from Investing 0.43
Cash from Financing -12.65
Net change in Cash -6.60
Free Cash Flow 7.39
Particulars MAR 2022 (Values in Cr)
Net Income -8.30
Cash from Operations 7.47
Cash from Investing 8.17
Cash from Financing -10.10
Net change in Cash 4.87
Free Cash Flow 8.88
Particulars MAR 2021 (Values in Cr)
Net Income -11.46
Cash from Operations -12.85
Cash from Investing -27.60
Cash from Financing -7.24
Net change in Cash -36.04
Free Cash Flow -12.32
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8496.80 62.45 12.89 122170.95 6680.00 8624.20
SHREE PACETRONIX LTD. 134.30 16.03 2.82 50.36 66.10 283.15
TRANSGENE BIOTEK LTD. 3.16 0.00 2.85 23.94 1.83 5.26
VIMTA LABS LTD. 478.55 35.16 6.23 2137.65 377.30 902.85
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8496.80 81.38 12.26 122170.95 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.25 0.00 -9.55 29.32 30.30 57.48
KOVAI MEDICAL CENTER & HO 5834.80 26.11 4.83 6383.27 5010.00 6725.00

FORTIS MALAR HOSPITALS LIMITED shareholding pattern

Holding
37.22%
62.7%
0.07%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

FORTIS MALAR HOSPITALS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
52.22 -0.09 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 52.60
  • 26 Days 53.50
  • 10 Days 52.90
  • 50 Days 53.80
  • 12 Days 53.00
  • 100 Days 55.00
  • 20 Days 53.40
  • 200 Days 57.80
52.39 PIVOT
First Support 49.88 First Resistance 54.78 Second Support 47.49 Second Resistance 57.29 Third Support 44.98 Third Resistance 59.68
RSI 42.00 ADX 15.52 MACD -0.53 Williams % R -73.57 Commodity Channel Index (CCI) -64.71
Date 2026-06-19 Week 5369.00 Same Day 3434.00 Month 5503.00
1 Year 0.85 3 Year 0.63
Over 1 Month
-4.60% down
Over 1 Year
-27.64% down
Over 3 Months
5.45% down
Over 3 Years
-1.20% down
Over 6 Months
-13.48% down
Over 5 Years
-4.86% down

FORTIS MALAR HOSPITALS LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
24 Jul 2024 2.5 Final 24 Jul 2024 Equity shares
23 Apr 2024 40.0 Interim 23 Apr 2024 Equity shares
14 Sep 2015 0.5 Final 16 Sep 2015 Equity shares
19 Sep 2013 0.5 Interim 20 Sep 2013 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Fortis Malar Hospitals Ltd?

Answer Field

Fortis Malar Hospitals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 52.22 as on Jun 19 2026 03:29 PM.

What is the Market Cap of Fortis Malar Hospitals Ltd Share?

Answer Field

The market cap of Fortis Malar Hospitals Ltd for NSE ₹ 0.00 & for BSE ₹ 97.90 as on Jun 19 2026 03:29 PM.

What is the 52 Week High and Low of Fortis Malar Hospitals Ltd?

Answer Field

The 52 Week High and Low of Fortis Malar Hospitals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 76.00 and ₹ 40.75.

What is 1 year return for Fortis Malar Hospitals Ltd?

Answer Field

The 1 year returns on the stock has been -27.64%.

What is the P/E Ratio of Fortis Malar Hospitals Ltd Share?

Answer Field

As on Jun 19 2026 03:29 PM the price-to-earnings (PE) ratio for Fortis Malar Hospitals Ltd share is 23.31.

What is the PB ratio of Fortis Malar Hospitals Ltd Share?

Answer Field

As on Jun 19 2026 03:29 PM, the price-to-book (PB) ratio for Fortis Malar Hospitals Ltd share is 18.22.

How to Buy Fortis Malar Hospitals Ltd Share?

Answer Field

You can trade in Fortis Malar Hospitals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Fortis Malar Hospitals Ltd Share on Bajaj Broking App?

Answer Field

To buy Fortis Malar Hospitals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Fortis Malar Hospitals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|